DocDollars

Merz North America, Inc.

NC · United States · Reporting entity ID 100000005376

Total reported 2019–2025
$32.2M
#224 of 2,960 reporting companies — 0% of all reported industry payments
$20.2M in general payments across 109,187 records, plus $12.0M in research funding across 1,370 records.

How it breaks down

General payments $20,197,653
Research funding $12,008,103

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Merz North America, Inc. reported $32.2M to US doctors and teaching hospitals from 2019 to 2025, ranking #224 of 2,960 reporting companies. 37% of that was research funding and 63% general payments such as consulting, speaking, food and travel. 109,187 general payment records and 1,370 research records were filed.

Common questions about Merz North America, Inc.

How much has Merz North America, Inc. paid US doctors?

Merz North America, Inc. reported $32,205,756 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $20,197,653 in general payments, $12,008,103 in research funding.

How does Merz North America, Inc. rank among drug and device companies?

It ranks #224 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Merz North America, Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.